FDA reports new deaths with diabetes drug Byetta
August 18, 2008 By MATTHEW PERRONE , AP Business Writer(AP) -- Federal regulators are working on a stronger label for a widely used diabetes drug marketed by Amylin Pharmaceuticals Inc. and Eli Lilly & Co. after deaths continue to be reported despite earlier government warnings.
Content from The Associated Press expires 15 days after original publication date. For more information about The Associated Press, please visit www.ap.org .
Similar stories from PHYSorg:
W. Africa's last giraffes make surprising comeback
10 hours ago |
not rated yet |
0
FDA warns Web companies not to sell flavored cigs
Nov 06, 2009 |
5 / 5 (1) |
2
States call on EPA for tougher air pollution regulations
Nov 06, 2009 |
3.2 / 5 (5) |
0
Community education and evacuation planning saved lives in Sept. 29 Samoan tsunami
Nov 05, 2009 |
not rated yet |
0
Nanotechnology: A risky frontier?
Nov 05, 2009 |
5 / 5 (4) |
0



In contrast, when a natural nutrient product causes similar trouble, the answer is usually to ban that product outright.
Double standard?